Back
ESC Premium Access

Platelet inhibition on brand and generic clopidogrel chronic therapy

Session: Safety issues with anti-platelets drugs
Topic: Antiplatelet Drugs
Speaker: Doctor A. Soliman (Dammam, SA)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Ahmad Soliman

Saud Al-Babtain Cardiac Center (SBCC), Dammam (Saudi Arabia)
1 presentation
0 follower

3 more presentations in this session

Perceived or calculated bleeding risk in patients undergoing percutaneous coronary intervention: inside the post-pci prospective registry

Speaker: Doctor M. Ferlini (Pavia, IT)

Access
Abstract
Like
Thumbnail

Are perceived or calculated bleeding risk related to dapt choice in patients undergoing percutaneous coronary intervention?

Speaker: Doctor M. Ferlini (Pavia, IT)

Access
Abstract
Like
Thumbnail

Adverse event profiles after brand or generic clopidogrel in the Food and Drug Administration Adverse Event Reporting System (FAERS)

Speaker: Associate Professor V. Serebruany (Baltimore, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Safety issues with anti-platelets drugs

Speakers: Doctor A. Soliman, Doctor M. Ferlini, Doctor M. Ferlini, Associate Professor V. Serebruany
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources